Zong, M., Zhao, H., Li, Q., Li, Y., & Zhang, J. (2020). Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway. Exp Ther Med.
Chicago Style CitationZong, Min, Hua Zhao, Qiang Li, Yanbing Li, i Jianjun Zhang. "Irbesartan Ameliorates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats By Inhibiting the TGFβ1/Smad2/3 Pathway." Exp Ther Med 2020.
Cita MLAZong, Min, et al. "Irbesartan Ameliorates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats By Inhibiting the TGFβ1/Smad2/3 Pathway." Exp Ther Med 2020.
Atenció: Aquestes cites poden no estar 100% correctes.